Istituto di Biofisica, Consiglio Nazionale delle Ricerche, Genoa, Italy.
J Gen Physiol. 2021 Jan 4;153(1). doi: 10.1085/jgp.202012583.
ClC-7 is a lysosomal 2 Cl-/1 H+ antiporter of the CLC protein family, which comprises Cl- channels and other Cl-/H+ antiporters. Mutations in ClC-7 and its associated β subunit Ostm1 lead to osteopetrosis and lysosomal storage disease in humans and mice. Previous studies on other mammalian CLC transporters showed that mutations of a conserved, intracellularly located glutamate residue, the so-called proton glutamate, abolish steady-state transport activity but increase transient capacitive currents associated with partial reactions of the transport cycle. In contrast, we observed large, transient capacitive currents for the wild-type ClC-7, which depend on external pH and internal, but not external, Cl-. Very similar transient currents were observed for the E312A mutant of the proton glutamate. Interestingly, and unlike in other mammalian CLC transporters investigated so far, the E312A mutation strongly reduces, but does not abolish, stationary transport currents, potentially explaining the intermediate phenotype observed in the E312A mouse line.
ClC-7 是 CLC 蛋白家族的溶酶体 2Cl-/1H+反向转运蛋白,该家族包括 Cl-通道和其他 Cl-/H+反向转运蛋白。ClC-7 及其相关的β亚基 Ostm1 的突变会导致人类和小鼠的骨质石化症和溶酶体贮积症。先前对其他哺乳动物 CLC 转运蛋白的研究表明,突变一个保守的、位于细胞内的谷氨酸残基,即所谓的质子谷氨酸,会消除稳态转运活性,但会增加与转运循环部分反应相关的短暂电容电流。相比之下,我们观察到野生型 ClC-7 的大、短暂电容电流,其依赖于外部 pH 值和内部,但不是外部,Cl-。对于质子谷氨酸的 E312A 突变体,观察到非常相似的短暂电流。有趣的是,与迄今为止研究的其他哺乳动物 CLC 转运蛋白不同,E312A 突变强烈降低但不会消除静止转运电流,这可能解释了在 E312A 小鼠品系中观察到的中间表型。